user

Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

被引：24
|
作者：
Bansal, Amar D. [1 ]
Hill, Chloe E. [2 ]
Berns, Jeffrey S. [1 ]
机构：
[1] Univ Penn, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
SEMINARS IN DIALYSIS | 2015年 / 28卷 / 04期
关键词：
GRANULOMATOUS INTERSTITIAL NEPHRITIS; ANTIDIURETIC-HORMONE SECRETION; HIGH-FLUX HEMODIALYSIS; PROTEIN-BINDING; PERITONEAL-DIALYSIS; PHARMACOKINETICS; CARBAMAZEPINE; LAMOTRIGINE; TOPIRAMATE; GABAPENTIN;
D O I：
10.1111/sdi.12385
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Epilepsy is a disorder with an approximate worldwide prevalence of 1%. Due to complexities of metabolism, protein-binding, renal elimination, and other pharmacokinetic parameters, the dosing of antiepileptic drugs (AEDs) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD) deserves special attention. This is a review of the most commonly prescribed AEDs with special focus on their indication, pharmacokinetics, and unique considerations for use in patients with CKD and ESRD. A review of their renal toxicities is also included.
引用
收藏
页码：404 / 412
页数：9
相关论文
共 50 条
  • [1] Use of antiepileptic drugs in patients with kidney disease
    Israni, Rubeen K.
    Kasbekar, Nishaminy
    Haynes, Kevin
    Berns, Jeffrey S.
    SEMINARS IN DIALYSIS, 2006, 19 (05) : 408 - 416
  • [2] Diuretic use in stage 5 chronic kidney disease and end-stage renal disease
    Sica, DA
    Gehr, TWB
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (05): : 483 - 490
  • [3] Inflammatory markers in chronic kidney disease and end stage renal disease patients
    Zakaria, Mahmoud M.
    Derbala, Safaa A.
    Salem, Ayman E.
    EL-Agroudy, Amgad E.
    El-Tantawy, Fatma M.
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (10) : 6857 - 6862
  • [4] Inflammatory markers in chronic kidney disease and end stage renal disease patients
    Mahmoud M. Zakaria
    Safaa A. Derbala
    Ayman E. Salem
    Amgad E. EL-Agroudy
    Fatma M. El-Tantawy
    Molecular Biology Reports, 2021, 48 : 6857 - 6862
  • [5] The burden of cardiovascular disease in patients with chronic kidney disease and in end-stage renal disease
    Zoccali, Carmine
    HEMODIALYSIS: FROM BASIC RESEARCH TO CLINICAL TRIALS, 2008, 161 : 63 - 67
  • [6] Periodontal Disease in Chronic Kidney Disease and End-Stage Renal Disease Patients: A Review
    Ariyamuthu, Venkatesh K.
    Nolph, Karl D.
    Ringdahl, Bruce E.
    CARDIORENAL MEDICINE, 2013, 3 (01) : 71 - 78
  • [7] HEMATURIA IS A RISK FACTOR FOR END STAGE RENAL DISEASE IN CHRONIC KIDNEY DISEASE PATIENTS
    Yen, Chun-Yu
    Wang, Hsiao-Han
    Hung, Chi-Chih
    Hwang, Shang-Jyh
    Chen, Hung-Chen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 128 - 128
  • [8] Sleeping disorders in patients with end-stage renal disease and chronic kidney disease
    De Santo, Rosa Maria
    Bartiromo, Marilu
    Cesare, Maria Concetta
    De Santo, Natale G.
    Cirillo, Massimo
    JOURNAL OF RENAL NUTRITION, 2006, 16 (03) : 224 - 228
  • [9] CHRONIC KIDNEY DISEASE, END STAGE RENAL DISEASE, AND KIDNEY TRANSPLANTATION IN SURINAME
    Panday, V. Nannan
    Diemer, F. S.
    Haan, Y. C.
    Punwasi, A.
    Rommy, C.
    Van Montfrans, G. A.
    Oehlers, G. P.
    Brewster, L. M.
    JOURNAL OF HYPERTENSION, 2017, 35 : E142 - E142
  • [10] Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review
    Vij, Aviral
    Golzar, Yasmeen
    Doukky, Rami
    JOURNAL OF NUCLEAR CARDIOLOGY, 2018, 25 (01) : 137 - 149
12345